Featured Research

from universities, journals, and other organizations

Gravity-defying ultrasonic tweezers could lead to life-changing medical advances

Date:
June 3, 2014
Source:
University of Southampton
Summary:
Researchers have developed pioneering ‘tweezers’ that use ultrasound beams to grip and manipulate tiny clusters of cells, which could lead to life-changing medical advances, such as better cartilage implants that reduce the need for knee replacement operations. Using ultrasonic sound fields, cartilage cells taken from a patient’s knee can be levitated for weeks in a nutrient-rich fluid.

Ultrasound beams levitating polystyrene balls.
Credit: Image courtesy of University of Southampton

Researchers from the University of Southampton have helped to develop pioneering 'tweezers' that use ultrasound beams to grip and manipulate tiny clusters of cells, which could lead to life-changing medical advances, such as better cartilage implants that reduce the need for knee replacement operations.

Using ultrasonic sound fields, cartilage cells taken from a patient's knee can be levitated for weeks in a nutrient-rich fluid. This means the nutrients can reach every part of the culture's surface and, combined with the stimulation provided by the ultrasound, enables the cells to grow and to form better implant tissue than when grown on a glass petri dish.

By holding the cells in the required position firmly but gently, the tweezers can also mould the growing tissue into exactly the right shape so that the implant is truly fit-for-purpose when inserted into the patient's knee. Over 75,000 knee replacements are carried out each year in the UK; many could be avoided if cartilage implants could be improved.

The ultrasonic tweezers were developed by researchers from the Universities of Southampton, Bristol, Dundee and Glasgow as well as a range of industrial partners.

Professor Martyn Hill, Head of the Engineering Sciences Unit at the University of Southampton, led the cartilage tissue engineering work in collaboration with colleagues Dr Peter Glynne-Jones, New Frontiers Fellow in Engineering Sciences, Dr Rahul Tare, a Lecturer in Musculoskeletal Science and Bioengineering, and Professor Richard Oreffo, a Professor of Musculoskeletal Science.

Professor Hill says: "Ultrasonic tweezers can provide what is, in effect, a zero-gravity environment perfect for optimising cell growth. As well as levitating cells, the tweezers can make sure that the cell agglomerates maintain a flat shape ideal for nutrient absorption. They can even gently massage the agglomerates in a way that encourages cartilage tissue formation."

Professor Bruce Drinkwater of Bristol University, who co-ordinated the programme, says: "Ultrasonic tweezers have all kinds of possible uses in bioscience, nanotechnology and more widely across industry. They offer big advantages over optical tweezers relying on light waves and also over electromagnetic methods of cell manipulation; for example, they have a complete absence of moving parts and can manipulate not just one or two cells at a time but clusters up to 1mm across -- a scale that makes them very suitable for applications like tissue engineering."

The tweezers, developed with Engineering and Physical Sciences Research Council (EPSRC) funding, involve multiple, tiny beams of ultrasonic waves that, in a typical device, point into a 10 mm-diameter chamber from all around. With the aid of a powerful microscope to monitor the procedure, the forces generated by the waves can then be manipulated so that they nudge cells into the required position, turn them around, or hold them firmly in place.

The research programme has also shown that ultrasonic tweezers can be used to build up cell tissue layer by layer, which could for instance, help to reconstruct nerve tissue after severe trauma such as limb amputation.

This research will enable ultrasonic tweezer technology to be refined and miniaturised and specific uses to be explored and developed in the next few years. The first real-world applications, in sectors such as bioscience and electronics, could potentially be developed within around five years.


Story Source:

The above story is based on materials provided by University of Southampton. Note: Materials may be edited for content and length.


Cite This Page:

University of Southampton. "Gravity-defying ultrasonic tweezers could lead to life-changing medical advances." ScienceDaily. ScienceDaily, 3 June 2014. <www.sciencedaily.com/releases/2014/06/140603092214.htm>.
University of Southampton. (2014, June 3). Gravity-defying ultrasonic tweezers could lead to life-changing medical advances. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2014/06/140603092214.htm
University of Southampton. "Gravity-defying ultrasonic tweezers could lead to life-changing medical advances." ScienceDaily. www.sciencedaily.com/releases/2014/06/140603092214.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins